🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lymph Nodes

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound NCT07357571n/a2 sites📍 Guangdong📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery NCT07140172NA55 sites📍 Bethesda📍 Durham📍 Philadelphia University Hospital, Basel, Switzerland · Tests: Axillary lymph node dissection (ALND), Axillary radiotherapy (ART) Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer NCT07844473NA1 site📍 Madinah King Faisal Specialist Hospital & Research Center · Tests: Super paramagnetic iron oxide bracketing injection Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC NCT06876753n/a2 sites📍 Nanjing📍 Nanjing Zhongda Hospital Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma NCT04594187Phase 23 sites📍 Jacksonville📍 Camden📍 Houston M.D. Anderson Cancer Center · Tests: Immunotherapy, Quality-of-Life Assessment, Radiation Therapy The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) NCT04555226NA1 site📍 Chongqing Chongqing University Cancer Hospital · Tests: Lymph node dissection, Standard chemoradiation±pembrolizumab, Chemoradiation± pembrolizumab Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer NCT06656949NA1 site📍 Jinan Qilu Hospital of Shandong University · Tests: injecting indocyanine green (ICG) dye Intraoperative Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes. NCT04019678NA1 site📍 Rozzano Istituto Clinico Humanitas · Tests: Omission of Axillary dissection Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation NCT04968990Phase 21 site📍 Memphis St. Jude Children's Research Hospital · Tests: Proton Beam Radiation (PBRT), DD-4A Chemotherapy Regimen, Complete Surgical Resection, Surgical Resection, Partial Neph… OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer NCT06935305NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: OSNA, Ultrastaging Molecular Signature From Tumor to Lymph Nodes NCT04677205n/a12 sites📍 Bordeaux📍 Clamart📍 Marseille Assistance Publique - Hôpitaux de Paris Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer NCT04845828NA1 site📍 Seoul Asan Medical Center · Tests: Sentinel lymph node mapping, Routine lymph node dissection Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision NCT06279299NA1 site📍 Beijing National Cancer Center, China · Tests: lateral pelvic lymph node dissection Multimodal Deep Learning for Lymph Node Metastasis Prediction and Physician Performance Assessment in T1 Gastric Cancer NCT07124754n/a1 site📍 Shijiazhuang Qun Zhao · Tests: Multimodal Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in T1 Gastric Cancer Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status NCT06713161n/a1 site📍 Kunming Yunnan Cancer Hospital · Tests: NIR-II Probe(i.e ICG-POL6326) incubation solution Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7% NCT07115992NA1 site📍 Shanghai Ruijin Hospital · Tests: RARP±SRT, RARP+ePLND Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19) NCT06775457NA5 sites📍 Carpi📍 Bologna📍 Modena IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: sample collection Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer NCT07003009NA1 site📍 Istanbul Istanbul Training and Research Hospital · Tests: Malign Lymph Node Washout, Benign Lymph Node Washout Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study NCT06689956n/a20 sites📍 Rochester📍 New York📍 Houston Mayo Clinic · Tests: Non-Interventional Study Description of Lymphatic Damage in Encephalic Venous Thrombosis and Strictures in MRI a Reverse-recovery Sequence: a Pilot Study NCT05041569n/a1 site📍 Paris Fondation Ophtalmologique Adolphe de Rothschild · Tests: MRI sequences Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer NCT06121570Phase 11 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Sentinel Lymph Node Biopsy (SLNB), Doxorubicin, Epirubicin, Cyclophosphamide, Cyclophosphamide Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup]) NCT07831824Phase 2, Phase 31 site📍 Grand Rapids Lantheus Medical Imaging · Tests: [68Ga]-LNTH-2401 Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation NCT07200466NA14 sites📍 Arnhem📍 Doetinchem📍 Ede Radboud University Medical Center · Tests: ENDORISK personalized risk assesment for lymph node metastases in endometrial cancer. A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors NCT06716619Phase 11 site📍 Guangzhou Guangzhou FineImmune Biotechnology Co., LTD. · Tests: Tumor Associated Lymph node T cell, Serplulimab Injection Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis NCT06517979n/a1 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Artificial intelligence (AI)-based diagnostic model Lymph Node Pathologic Grading Strategy NCT06745830n/a1 site📍 Shanghai Fudan University · Tests: No intervention MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer NCT06677112NA1 site📍 Lexington Rachel Miller · Tests: Selective surgical staging, REFLEX Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer NCT06671262Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: SBRT, Immuno-chemotherapy Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC) NCT07653503Phase 11 site📍 Groningen University Medical Center Groningen · Tests: Nivolumab Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial NCT07167160Phase 21 site📍 Hangzhou Women's Hospital School Of Medicine Zhejiang University · Tests: Camrelizumab combined with chemotherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy